Cannabinoid receptors as novel targets for the treatment of melanoma.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Cannabinoids in health and diseaseThe diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinAnticancer mechanisms of cannabinoidsCannabinoids as therapeutic agents in cancer: current status and future implicationsCannabinoids, endocannabinoids, and cancerPreclinical and Clinical Assessment of Cannabinoids as Anti-Cancer AgentsCrosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasionThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.CB2 receptor activation inhibits melanoma cell transmigration through the blood-brain barrier.Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivativesSynthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.In vivo type 2 cannabinoid receptor-targeted tumor optical imaging using a near infrared fluorescent probeSensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system.Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis.Leelamine mediates cancer cell death through inhibition of intracellular cholesterol transport.The alpha subunit of Go modulates cell proliferation and differentiation through interactions with Necdin.Cannabidiol as potential anticancer drug.β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells.Potentiation of the antitumor activity of adriamycin against osteosarcoma by cannabinoid WIN-55,212-2CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration.Cannabidiol inhibits angiogenesis by multiple mechanisms.Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor activation.The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer developmentModulating the endocannabinoid system in human health and disease--successes and failuresCritical appraisal of the potential use of cannabinoids in cancer management.Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells.The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities.CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.The endocannabinoid system and sex steroid hormone-dependent cancers.Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Update on the endocannabinoid system as an anticancer target."Sebocytes' makeup": novel mechanisms and concepts in the physiology of the human sebaceous glands.Antitumorigenic targets of cannabinoids - current status and implications.Dendritic Cell Regulation by Cannabinoid-Based DrugsRevisiting CB1 receptor as drug target in human melanoma.
P2860
Q24633122-517AA2F4-ECEE-4E6E-B5AD-9B88FEA6A040Q24633884-25EED2A5-EA6F-40A2-BE6F-DF946D8AC6E7Q24643876-0E05C5EC-6350-4993-AD53-6F8E6537AECAQ26750399-E9CBC601-3932-4171-8FAB-D0B4E811EC49Q26866298-BFBB583A-D7BA-46A4-9C40-1EEABE85BB2AQ27694715-44C9121F-E15B-4C17-B8D9-AFE8EC50054DQ28075903-227DCA3B-0B64-49F9-A11C-F008D40742B2Q28476823-92D18BF7-208E-4B5C-A800-A2B7064DDA89Q33623423-21AF6EC7-20AA-47E0-8700-F753C465410FQ33728086-C739C34F-1BEE-4A3C-911A-FF60740BC68EQ33755702-416B3AA5-682F-48CF-B169-F0C4B24A8314Q34004234-932F6031-DEDE-40D7-B843-780ED3EFF437Q34026054-2FBD8957-3F71-4E82-A63C-66978C2EEFA8Q34202076-783820C2-B6E1-4206-92BB-3B1B2B7D9F80Q34257434-4D191E41-1DE2-4542-9676-379822CA1DADQ34294075-D7D4A900-3A15-4FD3-9FD3-203FEF175D19Q34358271-4E2324A3-00E3-4DBC-96A0-B47583D43C40Q34413011-9329B835-2B6E-413B-A4AE-94346233F072Q34485623-FC3C383E-C719-4F6E-BB01-90EAECB68536Q34637516-F7D66881-D3AE-4FAC-947A-E9881C4B4F1DQ35854652-34ADF28D-8697-4BC4-87FB-6F651A1A4ABEQ35953952-61B4B174-A7EF-4369-81A0-07F4E0B41BE4Q36085919-420ECF0D-AD12-4348-88AA-7B63FD971DEAQ36416330-F8FB8B3B-FD1E-4A9A-927A-94B15CCDA4D2Q36419293-881E1532-24B7-443B-A9CF-EDC8A10BD2F4Q36473356-F0E9AD29-A3CA-4C6B-B592-39EB8F0B965DQ36666503-413C440D-2DFA-466B-8AA6-029E735CDAF4Q36933683-4C497DF9-B4D4-4A3B-9D5B-5C72C2E1D575Q37164208-AF948C9F-54F2-4073-AE17-AA62D519BCD2Q37223268-25AAA482-C34C-4A7D-8B91-33EFDCB5ACF7Q37375986-6ABB7892-5115-4DFA-97FE-F07B63306AADQ37386840-BFBC7F65-A5D7-4860-AAA3-ABDD9C0D3671Q37393042-A19A8001-62E7-49A2-A17D-BC88B3D7DFDBQ37490376-9CE20241-7471-4F5F-B29E-5DF1C1B20644Q37546194-9C16B4EB-6E23-472D-919E-209E46D16A89Q37829751-B0C69AAA-AA6A-4324-A65A-652D13AB1319Q37850705-D697E7E1-1B23-422A-818C-E5E692C7A09EQ38806270-9511B44C-7C86-4B75-8FD2-CD351F2DF8D3Q38974441-6EF52F67-8274-4F86-BFD7-8DD2DFCE7C73Q39374200-E01C4134-B70D-48E8-90E1-3BE0FBC9558A
P2860
Cannabinoid receptors as novel targets for the treatment of melanoma.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cannabinoid receptors as novel targets for the treatment of melanoma.
@ast
Cannabinoid receptors as novel targets for the treatment of melanoma.
@en
type
label
Cannabinoid receptors as novel targets for the treatment of melanoma.
@ast
Cannabinoid receptors as novel targets for the treatment of melanoma.
@en
prefLabel
Cannabinoid receptors as novel targets for the treatment of melanoma.
@ast
Cannabinoid receptors as novel targets for the treatment of melanoma.
@en
P2093
P50
P921
P356
P1433
P1476
Cannabinoid receptors as novel targets for the treatment of melanoma.
@en
P2093
Arkaitz Carracedo
Cristina Blázquez
José Luis Fernández-Luna
Lucía Barrado
Manuel Guzmán
P304
P356
10.1096/FJ.06-6638FJE
P407
P577
2006-10-25T00:00:00Z